Published Date: 06 Mar 2023
Oral desensitization using crushed sesame seeds and tahini may be a safe and effective method to desensitize pediatric patients with sesame allergy...
Read Full NewsImproving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches
Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer
Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer
Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer
Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer
Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly
Navigating Advances in Cystic Fibrosis Care
1.
What is Mohs micrographic surgery? 8 FAQs about Mohs
2.
Trump slashed US cancer research by 31 percent: Senate report
3.
NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.
4.
Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.
5.
Fear of hair loss might cause some to reject cancer treatment
1.
A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing
2.
A New Hope: Exploring the Potential of Pegaspargase in Treating Cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Obesity as a major risk factor for cancer
5.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I
2.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation